Search for: "Actavis"
Results 621 - 640
of 1,010
Sort by Relevance
|
Sort by Date
16 Jan 2014, 8:45 am
Actavis: The Patent-Antitrust Intersection Revisited. [read post]
6 Jan 2014, 7:59 pm
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "After Actavis: FTC Update" on January 9, 2014 beginning at 2:00 pm (ET). [read post]
27 Dec 2013, 1:27 am
Actavis disputed that French and Spanish law applied, but in any event began two further actions to assist in addressing Eli Lilly's procedural arguments. [read post]
20 Dec 2013, 11:30 am
Bloomberg, Actavis Managers Reap $115 Million After Buying Warner Chilcott Center on Budget and Policy Priorities, How Much Would a State Earned Income Tax Credit Cost in Fiscal Year 2015? [read post]
16 Dec 2013, 1:23 pm
Similarly in Actavis v Eli Lilly [2013] EWCA Civ 517, the Court of Appeal confirmed that the English courts have jurisdiction to hear claims for declarations of non-infringement in relation to foreign designations of European patents where there is no challenge to validity. [read post]
12 Dec 2013, 7:12 am
In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
22 Nov 2013, 2:40 pm
Actavis, Inc., et al., C.A. [read post]
18 Nov 2013, 11:40 am
Actavis PLC (NYSE: ACT) recently filed an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
17 Nov 2013, 8:56 pm
• Defendants: Watson Laboratories Inc; Actavis, Inc.; Actavis Pharma, Inc. [read post]
11 Nov 2013, 5:00 am
Actavis has... [read post]
6 Nov 2013, 9:35 pm
This referral follows three earlier referrals to the CJEU concerning the interpretation of the SPC Regulation in the cases of Actavis v Sanofi, Lilly v Human Genome Sciences and Georgetown University. [read post]
4 Nov 2013, 9:55 pm
Actavis sought a cross-undertaking that allowed (i) any company in the Actavis group and (ii) any customer or potential customer... [read post]
4 Nov 2013, 1:42 pm
Actavis South Atlantic LLC, et al., C.A. [read post]
4 Nov 2013, 12:00 am
Butler, George Mason University School of Law discuss Activating Actavis: Economic Issues in Applying the Rule of Reason to Reverse Payment Settlements. [read post]
28 Oct 2013, 12:43 pm
Linda Venczel as New Program Director --- Actavis's settles with FTC over $8.5 Billion acquisition of Warner Chilcott [read post]
28 Oct 2013, 12:43 pm
Mouse Model of Parkinson's Disease Shows Improved Brain Function --- DARPA Awards $25 Million To Develop Messenger RNA Therapeutics™ --- Actavis Files ANDA for Generic Suboxone® Sublingual Film --- AzaSite® Patents Upheld in Patent Infringement Lawsuit Against Sandoz --- Surgeons Successfully Remove "Inoperable" Metastatic Breast Cancer --- Actavis Files ANDA on Acanya® Gel, Gets Sued by Dow, Valeant --- NYSE Inquires About Unusual Market Activity for Ampio… [read post]
21 Oct 2013, 12:00 am
Aaron S. [read post]
20 Oct 2013, 8:00 pm
October 22, 2013 - Patent 'Trolls' Under Fire: Strategies, Tactics and Legislation Impacting University Patents & Licensing (Technology Transfer Tactics) - 1:00 to 2:00 pm (Eastern) October 22, 2013 - Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act Post-Actavis (American Bar Association Section of Intellectual Property Law, Young Lawyers Division, and Center for Professional Development) - 2:00 to 3:30 pm (Eastern) October 23, 2013 - European biotech patent law… [read post]
17 Oct 2013, 12:42 pm
He therefore permitted Actavis's wording in respect of the Actavis group. [read post]
